Evidence map›Paper›PMID 36584125›Full record

ArticlePloS one2022

"Living like an empty gas tank with a leak": Mixed methods study on post-acute sequelae of COVID-19.

Oluwabunmi Ogungbe, Sarah Slone, Abeer Alharthi, Tosin Tomiwa, Baridosia Kumbe, Alanna Bergman, Katherine McNabb, Rhonda Smith Wright, Jason E Farley, Cheryl R Dennison Himmelfarb and 4 more

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Oluwabunmi OgungbeSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.ORCID 0000-0003-1813-0906
Sarah SloneSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Abeer AlharthiSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.ORCID 0000-0001-7952-5851
Tosin TomiwaTexas Tech University, Lubbock, Texas, United States of America.ORCID 0000-0001-6388-0023
Baridosia KumbeSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Alanna BergmanCenter for Infectious Disease and Nursing Innovation, School of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Katherine McNabbCenter for Infectious Disease and Nursing Innovation, School of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Rhonda Smith WrightSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Jason E FarleySchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Cheryl R Dennison HimmelfarbSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Lisa A CooperSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Wendy S PostSchool of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
Patricia M DavidsonSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Yvonne Commodore-MensahSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Hopkins Center to Promote resilience in persons and families living with multiple chronic conditions (the PROMOTE Center)P30NR018093 · NINR · JOHNS HOPKINS UNIVERSITY · PI DENNISON HIMMELFARB, CHERYL · 2018 to 2022
$3.1M
Understanding and Predicting Loss to Follow-up from Multi-Drug Resistant Tuberculosis Treatment in the Setting of High-HIV BurdenF30AI165167 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MCNABB, KATHERINE C · 2021 to 2023
$149k
NIAID NIH HHS F30 AI165167NIAID NIH HHS P30 AI094189NINR NIH HHS P30 NR018093
6 · The paper itself

Abstract

backgroundThe burden and presentation of post-acute sequela of SARS-CoV-2 infection (PASC) are a developing major public health concern.

objectivesTo characterize the burden of PASC in community-dwelling individuals and understand the experiences of people living with PASC.

methodsThis mixed-methods study of COVID-19 positive community-dwelling persons involved surveys and in-depth interviews. Main outcome was self-report of possible PASC symptoms 3 weeks or longer after positive COVID-19 test. In-depth interviews were guided by a semi-structured interview guide with open-ended questions and probes based on emerging literature on PASC and the impact of COVID-19.

resultsWith a survey response rate of 70%, 442 participants were included in this analysis, mean (SD) age 45.4 (16.2) years, 71% female, 12% Black/African American. Compared to those with no PASC symptoms, persons who reported PASC symptoms were more likely to be older (mean age: 46.5 vs. 42; p = 0.013), female (74.3% vs. 61.2%; p = 0.010), to have pre-existing conditions (49.6% vs. 34%; p = 0.005), and to have been hospitalized for COVID-19 (14.2% vs. 2.9%; p = 0.002). About 30% of the participants experienced severe fatigue; the proportion of persons reporting severe fatigue was 7-fold greater in those with PASC symptoms (Adjusted Prevalence Ratio [aPR] 6.73, 95%CI: 2.80-16.18). Persons with PASC symptoms were more likely to report poor quality of life (16% vs. 5%, p<0.001) and worse mental health functioning (Mean difference: -1.87 95%CI: -2.38, -1.37, p<0.001). Themes from in-depth interviews revealed PASC was experienced as debilitating.

conclusionsIn this study, the prevalence of PASC among community-dwelling adults was substantial. Participants reported considerable coping difficulties, restrictions in everyday activities, invisibility of symptoms and experiences, and impediments to getting and receiving PASC care.

Indexed as

COVID-19AdultDisease ProgressionFatigueFemaleHumansMaleMiddle AgedQuality of LifeSARS-CoV-2Self Report

Identifiers

PMID36584125
PMCPMC9803174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.